Ranitidine in long-term duodenal ulcer treatment: A multicentre trial

F. Di Mario, O. Albano, G. Angelini, G. Cavallini, F. Doronzo, R. Farini, A. Francavilla, R. Naccarato, L. A. Scuro, F. Vianello

Research output: Contribution to journalArticle

Abstract

An endoscopically controlled clinical trial on maintenance Ranitidine treatment of scarred duodenal ulcer was carried out in 78 patients, randomly allocated to either 150 mg Ranitidine at night or low-dose antacid when necessary in a 1-year follow-up study. The maintenance Ranitidine regime prevented ulcer relapse in 23 of 31 cases (74.2%), without any significant adverse reaction. In the control group, the relapse was prevented in 12 of 30 cases (40%); the difference was found to be statistically significant.

Original languageEnglish
Pages (from-to)260-263
Number of pages4
JournalDigestion
Volume24
Issue number4
Publication statusPublished - 1982

Fingerprint

Ranitidine
Duodenal Ulcer
Multicenter Studies
Maintenance
Recurrence
Antacids
Controlled Clinical Trials
Ulcer
Therapeutics
Control Groups

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Di Mario, F., Albano, O., Angelini, G., Cavallini, G., Doronzo, F., Farini, R., ... Vianello, F. (1982). Ranitidine in long-term duodenal ulcer treatment: A multicentre trial. Digestion, 24(4), 260-263.

Ranitidine in long-term duodenal ulcer treatment : A multicentre trial. / Di Mario, F.; Albano, O.; Angelini, G.; Cavallini, G.; Doronzo, F.; Farini, R.; Francavilla, A.; Naccarato, R.; Scuro, L. A.; Vianello, F.

In: Digestion, Vol. 24, No. 4, 1982, p. 260-263.

Research output: Contribution to journalArticle

Di Mario, F, Albano, O, Angelini, G, Cavallini, G, Doronzo, F, Farini, R, Francavilla, A, Naccarato, R, Scuro, LA & Vianello, F 1982, 'Ranitidine in long-term duodenal ulcer treatment: A multicentre trial', Digestion, vol. 24, no. 4, pp. 260-263.
Di Mario F, Albano O, Angelini G, Cavallini G, Doronzo F, Farini R et al. Ranitidine in long-term duodenal ulcer treatment: A multicentre trial. Digestion. 1982;24(4):260-263.
Di Mario, F. ; Albano, O. ; Angelini, G. ; Cavallini, G. ; Doronzo, F. ; Farini, R. ; Francavilla, A. ; Naccarato, R. ; Scuro, L. A. ; Vianello, F. / Ranitidine in long-term duodenal ulcer treatment : A multicentre trial. In: Digestion. 1982 ; Vol. 24, No. 4. pp. 260-263.
@article{a3ad161100e542fab7e4888d468ba563,
title = "Ranitidine in long-term duodenal ulcer treatment: A multicentre trial",
abstract = "An endoscopically controlled clinical trial on maintenance Ranitidine treatment of scarred duodenal ulcer was carried out in 78 patients, randomly allocated to either 150 mg Ranitidine at night or low-dose antacid when necessary in a 1-year follow-up study. The maintenance Ranitidine regime prevented ulcer relapse in 23 of 31 cases (74.2{\%}), without any significant adverse reaction. In the control group, the relapse was prevented in 12 of 30 cases (40{\%}); the difference was found to be statistically significant.",
author = "{Di Mario}, F. and O. Albano and G. Angelini and G. Cavallini and F. Doronzo and R. Farini and A. Francavilla and R. Naccarato and Scuro, {L. A.} and F. Vianello",
year = "1982",
language = "English",
volume = "24",
pages = "260--263",
journal = "Digestion",
issn = "0012-2823",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Ranitidine in long-term duodenal ulcer treatment

T2 - A multicentre trial

AU - Di Mario, F.

AU - Albano, O.

AU - Angelini, G.

AU - Cavallini, G.

AU - Doronzo, F.

AU - Farini, R.

AU - Francavilla, A.

AU - Naccarato, R.

AU - Scuro, L. A.

AU - Vianello, F.

PY - 1982

Y1 - 1982

N2 - An endoscopically controlled clinical trial on maintenance Ranitidine treatment of scarred duodenal ulcer was carried out in 78 patients, randomly allocated to either 150 mg Ranitidine at night or low-dose antacid when necessary in a 1-year follow-up study. The maintenance Ranitidine regime prevented ulcer relapse in 23 of 31 cases (74.2%), without any significant adverse reaction. In the control group, the relapse was prevented in 12 of 30 cases (40%); the difference was found to be statistically significant.

AB - An endoscopically controlled clinical trial on maintenance Ranitidine treatment of scarred duodenal ulcer was carried out in 78 patients, randomly allocated to either 150 mg Ranitidine at night or low-dose antacid when necessary in a 1-year follow-up study. The maintenance Ranitidine regime prevented ulcer relapse in 23 of 31 cases (74.2%), without any significant adverse reaction. In the control group, the relapse was prevented in 12 of 30 cases (40%); the difference was found to be statistically significant.

UR - http://www.scopus.com/inward/record.url?scp=0020421672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020421672&partnerID=8YFLogxK

M3 - Article

C2 - 6295861

AN - SCOPUS:0020421672

VL - 24

SP - 260

EP - 263

JO - Digestion

JF - Digestion

SN - 0012-2823

IS - 4

ER -